Once Daily Pharma

The gallery of digital pharma marketing screenshots.

  • Browse by Drug Type
    • Prescription Drugs
    • Boxed Warning Drugs
  • Browse by Tactic
    • Pharma Banner Ads
    • Pharma on Social Media
    • Pharma Email Programs
    • Pharma Paid Search Ads
    • Pharma Website Features
    • Now Approved Websites
    • Now Available Websites
    • Launch Websites
  • Browse by Brand
  • Outside-the-Box
  • Unbranded Campaigns
  • Subscribe for Updates

Imlygic Now Approved

Nov 5, 2015



Brand: Imlygic (talimogene laherparepvec), Injectable Suspension
Parent Company: Amgen
Drug Type: Prescription
Drug Category: Oncology
Campaign: now-approved
Targeting: HCPs
Patient Website:
HCP Website: http://imlygic.com/

Now Approved, Websites. permalink 
  • Browse by Drug Type
  • Browse by Brand
  • Subscribe
  • Suggest an Example
  • Healthcare Marketing Agencies
  • Follow @OnceDailyPharma
  • Contact Us

Trademarks featured on this site are the property of their respective owners.
Materials provided under the Fair Use doctrine of the US Copyright Law.

© OnceDailyPharma. All rights reserved.
Theme credit: Unite
Join 2000+ top pharma marketers and get the latest updates in your inbox
  • This field is for validation purposes and should be left unchanged.

We’ll never share or sell your personal info. Ever.